Christopher Hoimes, DO

Publications

Merl, My, Cj Hoimes, T. Pham, and M Wasif Saif. “Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature previously presented: poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512).” Expert Opin Investig Drugs 18, no. 9 (September 2009): 1257–64. https://doi.org/10.1517/13543780903136724.

PMID
19678797
Full Text

Hoimes, Christopher J., Matthew T. Moyer, and Muhammad Wasif Saif. “Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.” Jop 10, no. 4 (July 6, 2009): 352–56.

PMID
19581733
Scholars@Duke

Strimpakos, Alexios S., Christopher Hoimes, and Muhammad Wasif Saif. “Pancreatic cancer: translating lessons from mouse models.” Jop 10, no. 2 (March 9, 2009): 98–103.

PMID
19287100
Scholars@Duke

Hoimes, Christopher J., Alexios S. Strimpakos, and Muhammad Wasif Saif. “Therapeutic tools in pancreatic cancer.” Jop 10, no. 2 (March 9, 2009): 118–22.

PMID
19287103
Scholars@Duke

Dodson, Cassidy, Daniel A. Smith, Tyler J. Richards, Robert R. Devita, Christopher J. Hoimes, and Nikhil H. Ramaiya. “Systemic Therapies for Melanoma Brain Metastases: A Primer for Radiologists.” J Comput Assist Tomogr 44, no. 3 (n.d.): 346–55. https://doi.org/10.1097/RCT.0000000000001006.

PMID
32217896
Full Text

Liput, Joseph, Ezgi Guler, Daniel A. Smith, Sree Harsha Tirumani, Christopher Hoimes, Paolo F. Caimi, and Nikhil H. Ramaiya. “Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience.” J Comput Assist Tomogr 44, no. 4 (n.d.): 619–26. https://doi.org/10.1097/RCT.0000000000001043.

PMID
32558769
Full Text

Pages